UnknownPHASE2, PHASE3NCT04453345

TPM Regimen (Thalidomide, Prednisone and Methotrexate) in LGLL

Studying Neutropenia-hyperlymphocytosis with large granular lymphocytes syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Principal Investigator
Lugui Qiu
Blood Disease Hospital, CAMS and Peking Union Medical College
Intervention
thalidomide + prednisone + methotrexate(drug)
Enrollment
42 enrolled
Eligibility
18 years · All sexes
Timeline
20132025

Study locations (9)

Collaborators

The First Affiliated Hospital of Nanchang University · First Affiliated Hospital of Guangxi Medical University · Henan Cancer Hospital · The First Hospital of Jilin University · Central South University · Tianjin First Central Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04453345 on ClinicalTrials.gov

Other trials for Neutropenia-hyperlymphocytosis with large granular lymphocytes syndrome

Additional recruiting or active studies for the same condition.

See all trials for Neutropenia-hyperlymphocytosis with large granular lymphocytes syndrome

← Back to all trials